Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Stocks of Local Interest
PG Energy Index
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Meiragtx Holdings Plc
(NQ:
MGTX
)
13.08
USD
-0.27 (-2.02%)
Official Closing Price
Updated: 5:11 PM EDT, Apr 12, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Meiragtx Holdings Plc
< Previous
1
2
Next >
MeiraGTx Reports Fourth Quarter and Full Year 2020 Financial and Operational Results
March 11, 2021
From
GlobeNewswire News Releases
MeiraGTx to Present at the 2021 Barclays Global Healthcare Conference
March 04, 2021
From
GlobeNewswire News Releases
Graviton Enters into Global Licensing Agreement for ROCK2 Inhibitor from Beijing Tide
February 23, 2021
Founder Samuel D. Waksal, Ph.D., to lead Graviton in developing therapeutics in autoimmune diseases, various cancers, certain genetic diseases, fibrotic and other disorders for which there is current...
From
PR Newswire
MeiraGTx Announces AAV-CNGA3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia
January 26, 2021
From
GlobeNewswire News Releases
MeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia
December 16, 2020
Webcast and conference call to take place on December 17, 2020 at 8:00 a.m. ET
From
GlobeNewswire News Releases
MeiraGTx to Participate in the Evercore ISI 3rd Annual HealthCONx Conference
November 30, 2020
From
GlobeNewswire News Releases
MeiraGTx to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 23, 2020
From
GlobeNewswire News Releases
MeiraGTx Announces Pricing of Public Offering of Ordinary Shares
November 19, 2020
From
GlobeNewswire News Releases
MeiraGTx Announces Proposed Public Offering of Ordinary Shares
November 18, 2020
From
GlobeNewswire News Releases
MeiraGTx Announces Investigational Gene Therapy Continues to Demonstrate Statistically Significant Improvement in Vision in Patients with X-Linked Retinitis Pigmentosa One Year After Treatment
November 13, 2020
Data presented at AAO 2020 Virtual Annual Meeting show sustained improvements in retinal sensitivity at 12 months
From
GlobeNewswire News Releases
MeiraGTx to Present at the Barclays Gene Editing & Gene Therapy Summit
November 10, 2020
From
GlobeNewswire News Releases
MeiraGTx Reports Third Quarter 2020 Financial Results
November 05, 2020
From
GlobeNewswire News Releases
MeiraGTx Announces Data from Ongoing Clinical Trial of AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa to be Presented at AAO 2020 Virtual Meeting
October 28, 2020
12-Month Dose Escalation Data from Phase 1/2 Clinical Trial to be Presented
From
GlobeNewswire News Releases
MeiraGTx Announces Nine-Month Data from Phase 1/2 Trial of AAV-RPGR Demonstrating Significant and Sustained Vision Improvement in X-Linked Retinitis Pigmentosa (XLRP)
October 03, 2020
From
GlobeNewswire News Releases
MeiraGTx to Present at the Chardan 4th Annual Genetic Medicines Conference
September 28, 2020
From
GlobeNewswire News Releases
MeiraGTx Announces Data from Ongoing Clinical Trial of AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa to be Presented at EURETINA 2020 Virtual Meeting
September 22, 2020
- Nine-Month Follow-Up Data to be Presented -
From
GlobeNewswire News Releases
MeiraGTx Reports Second Quarter 2020 Financial Results
August 06, 2020
From
GlobeNewswire News Releases
MeiraGTx Expands Leadership Team with Appointment of Robert K. Zeldin, M.D. as Chief Medical Officer
August 05, 2020
From
GlobeNewswire News Releases
MeiraGTx Announces Positive Clinical Data Demonstrating Treatment with AAV-RPGR Investigational Gene Therapy Improves Vision in X-Linked Retinitis Pigmentosa Patients
July 17, 2020
From
GlobeNewswire News Releases
MeiraGTx Announces Move to Virtual-Only Format for 2020 Annual General Meeting of Shareholders
May 26, 2020
From
GlobeNewswire News Releases
MeiraGTx Reports First Quarter 2020 Financial Results
May 07, 2020
From
GlobeNewswire News Releases
Kadmon Provides Business Update and Reports First Quarter 2020 Financial Results
May 07, 2020
From
ACCESSWIRE
MeiraGTx to Present at the Virtual Bank of America Securities 2020 Health Care Conference
May 06, 2020
From
GlobeNewswire News Releases
MeiraGTx Reports Full Year 2019 Financial Results
March 11, 2020
From
GlobeNewswire News Releases
MeiraGTx Announces Priority Medicines (PRIME) and Advanced Therapy Medicinal Product (ATMP) Designations Granted by the European Medicines Agency to AAV-RPGR Gene Therapy for the Treatment of X-Linked
March 02, 2020
From
GlobeNewswire News Releases
MeiraGTx to Present at Upcoming Investor Conferences
February 24, 2020
From
GlobeNewswire News Releases
MeiraGTx to Host Parkinson’s Disease R&D Day in New York
December 05, 2019
From
GlobeNewswire News Releases
MeiraGTx to Present at Upcoming Healthcare Conferences
November 26, 2019
From
GlobeNewswire News Releases
Kadmon Provides Business Update and Reports Third Quarter 2019 Financial Results
November 07, 2019
From
ACCESSWIRE
MeiraGTx Reports Third Quarter 2019 Financial Results
November 07, 2019
From
GlobeNewswire News Releases
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.